Association of receiving a fourth dose of the BNT162b vaccine with SARS-CoV-2 infection among health care workers in Israel
Importance Despite the high 3-dose vaccination rate among health care workers (HCWs) in
Israel, a high rate of SARS-CoV-2 breakthrough infections in this group was observed during …
Israel, a high rate of SARS-CoV-2 breakthrough infections in this group was observed during …
Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among health care workers in Israel
Importance Administration of a BNT162b2 booster dose (Pfizer-BioNTech) to fully
vaccinated individuals aged 60 years and older was significantly associated with lower risk …
vaccinated individuals aged 60 years and older was significantly associated with lower risk …
Association between vaccination with BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among health care workers
Importance Randomized clinical trials have provided estimates of the effectiveness of the
BNT162b2 vaccine against symptomatic SARS-CoV-2 infection, but its effect on …
BNT162b2 vaccine against symptomatic SARS-CoV-2 infection, but its effect on …
Association of receipt of the fourth BNT162b2 dose with Omicron infection and COVID-19 hospitalizations among residents of long-term care facilities
Importance The administration of a fourth BNT162b2 COVID-19 vaccine dose was approved
in Israel in December 2021 for individuals 60 years or older who were vaccinated with a …
in Israel in December 2021 for individuals 60 years or older who were vaccinated with a …
Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1–2 IgG antibody titers in healthcare personnel
ME Romero-Ibarguengoitia, D Rivera-Salinas… - PLoS …, 2022 - journals.plos.org
Background Vaccination is our main strategy to control SARS-CoV-2 infection. Given the
decrease in quantitative SARS-CoV-2 spike 1–2 IgG antibody titers three months after the …
decrease in quantitative SARS-CoV-2 spike 1–2 IgG antibody titers three months after the …
[HTML][HTML] T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre …
Background Previous infection with SARS-CoV-2 affects the immune response to the first
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational …
L Seekircher, Z Bánki, J Kimpel, A Rössler… - The Lancet …, 2023 - thelancet.com
Background Correlates of protection could help to assess the extent to which a person is
protected from SARS-CoV-2 infection after vaccination (so-called breakthrough infection) …
protected from SARS-CoV-2 infection after vaccination (so-called breakthrough infection) …
[HTML][HTML] BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health …
Y Lustig, E Sapir, G Regev-Yochay… - The Lancet …, 2021 - thelancet.com
Summary Background Concurrent with the Pfizer–BioNTech BNT162b2 COVID-19 vaccine
roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and …
roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and …
Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers
Methods| The study was approved by the Humanitas Research Hospital institutional review
board. Each participant provided written informed consent. We conducted an observational …
board. Each participant provided written informed consent. We conducted an observational …
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA. 1 and BA. 2 …
SY Tartof, JM Slezak, L Puzniak, V Hong… - The Lancet …, 2023 - thelancet.com
Summary Background The SARS-CoV-2 omicron (B. 1.1. 529 BA. 1) lineage was first
detected in November, 2021, and is associated with reduced vaccine effectiveness. By …
detected in November, 2021, and is associated with reduced vaccine effectiveness. By …
相关搜索
- sars cov bnt162b2 vaccine
- sars cov health care
- sars cov breakthrough infection
- omicron infection bnt162b2 dose
- bnt162b2 vaccine healthcare personnel
- association of receipt bnt162b2 dose
- omicron infection association of receipt
- sars cov open label
- sars cov immune response
- sars cov healthcare personnel
- sars cov bnt162b2 covid
- sars cov vaccination with bnt162b2